Amyloids or prions? That is the question.

Despite major efforts devoted to understanding the phenomenon of prion transmissibility, it is still poorly understood how this property is encoded in the amino acid sequence. In recent years, experimental data on yeast prion domains allow to start at least partially decrypting the sequence requirem...

Descripción completa

Detalles Bibliográficos
Autores: Sabate R, Rousseau F, Schymkowitz J, Batlle C, Ventura S
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Fundació Sant Joan de Déu
Repositorio:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
OAI Identifier:oai:fsjd.fundanetsuite.com:p18905
Acceso en línea:https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18905
Access Level:acceso abierto
Palabra clave:AD, Alzheimer's disease
CJD, Creutzfeldt-Jakob disease
PD, Parkinson's disease
PFD, prion forming domain
Q/N-rich domains
TSE, transmissible spongiform encephalopathy
amyloids
fALS, familial amyotrophic lateral sclerosis
neurodegenerative diseases
prions
protein intrinsic disorder
yeast
Descripción
Sumario:Despite major efforts devoted to understanding the phenomenon of prion transmissibility, it is still poorly understood how this property is encoded in the amino acid sequence. In recent years, experimental data on yeast prion domains allow to start at least partially decrypting the sequence requirements of prion formation. These experiments illustrate the need for intrinsically disordered sequence regions enriched with a particularly high proportion of glutamine and asparagine. Bioinformatic analysis suggests that these regions strike a balance between sufficient amyloid nucleation propensity on the one hand and disorder on the other, which ensures availability of the amyloid prone regions but entropically prevents unwanted nucleation and facilitates brittleness required for propagation.